A molecule that lies dormant until it encounters a cancer cell, then suddenly activates and rouses the body's immune system to fight cancer cells directly, marks the latest step in scientists' efforts to tap the body's own resources to fight the disease.
As in previous years, proceeds raised at the dunk tank and canning during Blue-White Weekend will benefit the Kidney Cancer Association.
British scientists have created human kidneys from stem cells in a breakthrough which could result in transplant patients growing their own organs.
The pivotal Phase III study will evaluate as the primary endpoint the overall survival of advanced renal cell carcinoma patients treated with IMA901 in combination with Pfizer's Sutent(R) (sunitinib malate) versus Sutent(R) alone.
The urinary system under attack does not perform to its optimal level and WBC escape through the urine during this time.
The medicine has successfully been tested for the treatment of breast, bone, liver, and kidney cancer, which are the most resistant cancers...
Surgeons at University of Rochester Medical Center in New York state, US, have become the first in the country to use a new infrared imaging technique combined with robot-assisted surgery to remove kidney cancer.
"One of the draw backs to the use of interluekin as an anti cancer agent is its toxicity. When given intravenously in the sort of dose that you had to administer to have an effect on kidney cancer, it was extremely toxic and even dangerous..."
Snapshots taken during the 2011 National Patients & Survivors Conference held at M. D. Anderson Cancer Center, Houston, Texas, Saturday, April 9, 2011.
Despite novel targeted agents, prognosis of metastatic renal cell cancer (RCC) remains poor, and experimental therapeutic strategies are warranted